ELI LILLY AND COMPANY Payments to Acquire Other Property, Plant, and Equipment
ELI LILLY AND COMPANY (LLY) reported Payments to Acquire Other Property, Plant, and Equipment of $5.26 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment · last filed 2026-08-05
- ELI LILLY AND COMPANY payments to acquire other property, plant, and equipment for the quarter ending 2026-06-30 was $2.93B, a 72.83% increase year-over-year.
- ELI LILLY AND COMPANY payments to acquire other property, plant, and equipment for the quarter ending 2026-03-31 was $2.33B, a 54.04% increase year-over-year.
- ELI LILLY AND COMPANY payments to acquire other property, plant, and equipment for the quarter ending 2025-12-31 was $2.55B, a 70.21% increase year-over-year.
- ELI LILLY AND COMPANY payments to acquire other property, plant, and equipment for the quarter ending 2025-09-30 was $2.09B, a 54.53% increase year-over-year.
- ELI LILLY AND COMPANY payments to acquire other property, plant, and equipment for fiscal 2025 was $7.84B, a 55.02% increase from fiscal 2024.
- ELI LILLY AND COMPANY payments to acquire other property, plant, and equipment for fiscal 2024 was $5.06B, a 46.69% increase from fiscal 2023.
- ELI LILLY AND COMPANY payments to acquire other property, plant, and equipment for fiscal 2023 was $3.45B, a 85.95% increase from fiscal 2022.
- ELI LILLY AND COMPANY payments to acquire other property, plant, and equipment for fiscal 2022 was $1.85B, a 41.57% increase from fiscal 2021.
| Period end | Payments to Acquire Other Property, Plant, and Equipment 3 month | Payments to Acquire Other Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Other Property, Plant, and Equipment 6 month | Payments to Acquire Other Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Other Property, Plant, and Equipment 9 month | Payments to Acquire Other Property, Plant, and Equipment 12 month | Payments to Acquire Other Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.93B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.26B 10-Q · filed 2026-08-05 | $7.81B derived: sum of 3 quarters · filed 2026-08-05 | $9.89B derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $2.33B 10-Q · filed 2026-04-30 | $4.87B derived: sum of 2 quarters · filed 2026-04-30 | $6.96B derived: sum of 3 quarters · filed 2026-04-30 | $8.66B derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $2.55B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $4.63B derived: sum of 2 quarters · filed 2026-02-12 | $6.33B derived: sum of 3 quarters · filed 2026-08-05 | $7.84B 10-K · filed 2026-02-12 | |||
| 2025-09-30 | $2.09B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.78B derived: sum of 2 quarters · filed 2026-08-05 | $5.29B 10-Q · filed 2025-10-30 | $6.79B derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $1.70B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.21B 10-Q · filed 2026-08-05 | $3.21B 10-Q · filed 2025-08-07 | $4.70B derived: sum of 3 quarters · filed 2026-08-05 | $6.05B derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $1.51B 10-Q · filed 2026-04-30 | $1.51B 10-Q · filed 2025-05-01 | $3.01B derived: sum of 2 quarters · filed 2026-04-30 | $4.36B derived: sum of 3 quarters · filed 2026-04-30 | $5.58B derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | $1.50B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $2.85B derived: sum of 2 quarters · filed 2026-02-12 | $4.07B derived: sum of 3 quarters · filed 2026-02-12 | $5.06B 10-K · filed 2026-02-12 | $5.06B 10-K · filed 2025-02-19 | ||
| 2024-09-30 | $1.35B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.58B derived: sum of 2 quarters · filed 2025-10-30 | $3.56B 10-Q · filed 2025-10-30 | $4.63B derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-06-30 | $1.22B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.21B 10-Q · filed 2025-08-07 | $3.28B derived: sum of 3 quarters · filed 2026-02-12 | $4.25B derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-03-31 | $986.30M 10-Q · filed 2025-05-01 | $2.06B derived: sum of 2 quarters · filed 2026-02-12 | $3.03B derived: sum of 3 quarters · filed 2026-02-12 | $3.77B derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2023-12-31 | $1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $2.04B derived: sum of 2 quarters · filed 2026-02-12 | $2.78B derived: sum of 3 quarters · filed 2026-02-12 | $3.45B 10-K · filed 2026-02-12 | $3.45B 10-K · filed 2024-02-21 | ||
| 2023-09-30 | $970.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $1.71B derived: sum of 2 quarters · filed 2024-10-30 | $2.38B 10-Q · filed 2024-10-30 | $2.88B derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2023-06-30 | $738.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.41B 10-Q · filed 2024-08-08 | $1.91B derived: sum of 3 quarters · filed 2025-02-19 | $2.52B derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2023-03-31 | $668.50M 10-Q · filed 2024-04-30 | $1.17B derived: sum of 2 quarters · filed 2025-02-19 | $1.79B derived: sum of 3 quarters · filed 2025-02-19 | $2.16B derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2022-12-31 | $500.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $1.12B derived: sum of 2 quarters · filed 2025-02-19 | $1.49B derived: sum of 3 quarters · filed 2025-02-19 | $1.85B 10-K · filed 2025-02-19 | |||
| 2022-09-30 | $617.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $988.20M derived: sum of 2 quarters · filed 2023-11-02 | $1.35B 10-Q · filed 2023-11-02 | ||||
| 2022-06-30 | $371.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $736.40M 10-Q · filed 2023-08-08 | |||||
| 2022-03-31 | $365.40M 10-Q · filed 2023-04-27 | ||||||
| 2021-12-31 | $1.31B 10-K · filed 2024-02-21 | ||||||
| 2020-12-31 | $1.39B 10-K · filed 2023-02-22 | ||||||
| 2019-12-31 | $1.03B 10-K · filed 2022-02-23 | ||||||
| 2018-12-31 | $1.21B 10-K · filed 2021-02-17 | ||||||
| 2017-12-31 | $1.08B 10-K · filed 2020-02-19 | ||||||
| 2016-12-31 | $1.04B 8-K · filed 2019-10-24 | ||||||
| 2015-12-31 | $1.07B 10-K · filed 2018-02-20 | ||||||
| 2014-12-31 | $1.16B 10-K · filed 2017-02-21 | ||||||
| 2013-12-31 | $1.01B 10-K · filed 2016-02-19 | ||||||
| 2012-12-31 | $905.40M 10-K · filed 2015-02-19 | ||||||
| 2011-12-31 | $672.00M 10-K · filed 2014-02-19 | ||||||
| 2010-12-31 | $694.30M 10-K · filed 2013-02-21 | ||||||
| 2009-12-31 | $765.00M 10-K · filed 2012-02-24 | ||||||
| 2008-12-31 | $947.20M 10-K · filed 2011-02-22 | ||||||
| 2007-12-31 | $1.08B 10-K · filed 2010-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |